DXCM
Price
$72.10
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
100 days until earnings call
TNDM
Price
$32.75
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

DXCM vs TNDM

Header iconDXCM vs TNDM Comparison
Open Charts DXCM vs TNDMBanner chart's image
DexCom
Price$72.10
Change-$0.00 (-0.00%)
Volume$5.57M
CapitalizationN/A
Tandem Diabetes Care
Price$32.75
Change-$0.00 (-0.00%)
Volume$1.55M
CapitalizationN/A
View a ticker or compare two or three
DXCM vs TNDM Comparison Chart
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DXCM vs. TNDM commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a StrongBuy and TNDM is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (DXCM: $72.09 vs. TNDM: $32.75)
Brand notoriety: DXCM and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 115% vs. TNDM: 132%
Market capitalization -- DXCM: $53.47B vs. TNDM: $2.32B
DXCM [@Medical Specialties] is valued at $53.47B. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 0 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 0 green, 5 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while TNDM’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 5 bearish.
  • TNDM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DXCM is a better buy in the short-term than TNDM.

Price Growth

DXCM (@Medical Specialties) experienced а -0.72% price change this week, while TNDM (@Medical Specialties) price change was -3.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

DXCM is expected to report earnings on Feb 06, 2025.

TNDM is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($53.5B) has a higher market cap than TNDM($2.32B). TNDM has higher P/E ratio than DXCM: TNDM (666.67) vs DXCM (106.11). TNDM YTD gains are higher at: 10.717 vs. DXCM (-41.905). DXCM has higher annual earnings (EBITDA): 917M vs. TNDM (-196.97M). DXCM has more cash in the bank: 2.72B vs. TNDM (468M). TNDM has less debt than DXCM: TNDM (416M) vs DXCM (2.59B). DXCM has higher revenues than TNDM: DXCM (3.62B) vs TNDM (748M).
DXCMTNDMDXCM / TNDM
Capitalization53.5B2.32B2,302%
EBITDA917M-196.97M-466%
Gain YTD-41.90510.717-391%
P/E Ratio106.11666.6716%
Revenue3.62B748M484%
Total Cash2.72B468M582%
Total Debt2.59B416M624%
FUNDAMENTALS RATINGS
DXCM vs TNDM: Fundamental Ratings
DXCM
TNDM
OUTLOOK RATING
1..100
553
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
3496
PRICE GROWTH RATING
1..100
5763
P/E GROWTH RATING
1..100
9792
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (74) in the Medical Specialties industry is in the same range as TNDM (98). This means that DXCM’s stock grew similarly to TNDM’s over the last 12 months.

DXCM's Profit vs Risk Rating (66) in the Medical Specialties industry is somewhat better than the same rating for TNDM (100). This means that DXCM’s stock grew somewhat faster than TNDM’s over the last 12 months.

DXCM's SMR Rating (34) in the Medical Specialties industry is somewhat better than the same rating for TNDM (96). This means that DXCM’s stock grew somewhat faster than TNDM’s over the last 12 months.

DXCM's Price Growth Rating (57) in the Medical Specialties industry is in the same range as TNDM (63). This means that DXCM’s stock grew similarly to TNDM’s over the last 12 months.

TNDM's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as DXCM (97). This means that TNDM’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMTNDM
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
74%
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-1.84%
CERS - DXCM
42%
Loosely correlated
+2.99%
IRMD - DXCM
34%
Loosely correlated
+3.42%
AORT - DXCM
33%
Loosely correlated
-0.04%
ACRS - DXCM
33%
Loosely correlated
-4.73%
COO - DXCM
32%
Poorly correlated
-2.14%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with NVRO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then NVRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+4.47%
NVRO - TNDM
40%
Loosely correlated
+7.21%
LMAT - TNDM
35%
Loosely correlated
+1.96%
MMSI - TNDM
35%
Loosely correlated
-0.72%
STE - TNDM
35%
Loosely correlated
-0.05%
RDNT - TNDM
34%
Loosely correlated
+1.08%
More